Although snoring is usually seen as a social nuisance, modern medicine regards it as an important signal about our health. Especially when it is combined with obstructive sleep apnoea (OSA), the lack of oxygen the body is exposed to through the night brings serious risks.
The scientific reality: what does untreated apnoea lead to?
Large studies and expert bodies (AASM, ERS) agree on one point: untreated sleep apnoea significantly increases the long-term risk of cardiovascular disease, metabolic disorders, cognitive decline and even early death. With regular treatment, however, these risks can be minimised.
Which treatment is the first choice for snoring?
Should every patient have surgery? Scientific guidelines recommend non-surgical methods first for snoring and mild to moderate apnoea:
- PAP (positive airway pressure) therapy: the first option, regarded as the gold standard in adults.
- Oral appliances: devices that bring the lower jaw forward are very effective in patients who cannot adapt to a PAP machine.
- Myofunctional therapy: specific exercises that strengthen the muscles of the upper airway offer a non-surgical, low-risk option.
When is surgery needed?
Surgery is considered the first option particularly in children (in apnoea caused by enlarged adenoids and tonsils). In adults, surgery can reduce snoring markedly, but patient selection is critical for lasting success. It should be borne in mind that the benefit gained in the first years after surgery may lessen over time, and that there is a risk of complications.
References
- Patil SP, Ayappa IA, Caples SM, et al. Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. 2019;15(2):335–343. doi:10.5664/jcsm.7640
- Ramar K, Dort LC, Katz SG, et al. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. Journal of Clinical Sleep Medicine. 2015;11(7):773–827. doi:10.5664/jcsm.4858
- Randerath W, Verbraecken J, de Raaff CAL, et al. European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea. European Respiratory Review. 2021;30(162):210200. doi:10.1183/16000617.0200-2021
- Camacho M, Certal V, Abdullatif J, et al. Myofunctional Therapy to Treat Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. Sleep. 2015;38(5):669–675. doi:10.5665/sleep.4652
- Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):576–584. doi:10.1542/peds.2012-1671
- Kent D, Stanley J, Aurora RN, et al. Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(12):2499–2505. doi:10.5664/jcsm.9592
- Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet. 2005;365(9464):1046–1053. doi:10.1016/S0140-6736(05)71141-7